Alisa M. Goldstein
Genetic Epidemiology Branch
Division of Cancer Epidemiologyand Genetics/NCI/NIH/DHHS
Executive Plaza South
Room 7004
USA
Name/email consistency: high
- CDKN2A mutations and melanoma risk in the Icelandic population. Goldstein, A.M., Stacey, S.N., Olafsson, J.H., Jonsson, G.F., Helgason, A., Sulem, P., Sigurgeirsson, B., Benediktsdottir, K.R., Thorisdottir, K., Ragnarsson, R., Kjartansson, J., Kostic, J., Masson, G., Kristjansson, K., Gulcher, J.R., Kong, A., Thorsteinsdottir, U., Rafnar, T., Tucker, M.A., Stefansson, K. J. Med. Genet. (2008)
- Cutaneous phenotype and MC1R variants as modifying factors for the development of melanoma in CDKN2A G101W mutation carriers from 4 countries. Goldstein, A.M., Chaudru, V., Ghiorzo, P., Badenas, C., Malvehy, J., Pastorino, L., Laud, K., Hulley, B., Avril, M.F., Puig-Butille, J.A., Miniere, A., Marti, R., Chompret, A., Cuellar, F., Kolm, I., Mila, M., Tucker, M.A., Demenais, F., Bianchi-Scarra, G., Puig, S., de-Paillerets, B.B. Int. J. Cancer (2007)
- Features associated with germline CDKN2A mutations: a GenoMEL study of melanoma-prone families from three continents. Goldstein, A.M., Chan, M., Harland, M., Hayward, N.K., Demenais, F., Bishop, D.T., Azizi, E., Bergman, W., Bianchi-Scarra, G., Bruno, W., Calista, D., Albright, L.A., Chaudru, V., Chompret, A., Cuellar, F., Elder, D.E., Ghiorzo, P., Gillanders, E.M., Gruis, N.A., Hansson, J., Hogg, D., Holland, E.A., Kanetsky, P.A., Kefford, R.F., Landi, M.T., Lang, J., Leachman, S.A., MacKie, R.M., Magnusson, V., Mann, G.J., Bishop, J.N., Palmer, J.M., Puig, S., Puig-Butille, J.A., Stark, M., Tsao, H., Tucker, M.A., Whitaker, L., Yakobson, E. J. Med. Genet. (2007)
- Unconditional analyses can increase efficiency in assessing gene-environment interaction of the case-combined-control design. Goldstein, A.M., Dondon, M.G., Andrieu, N. Int. J. Epidemiol (2006)
- High-risk melanoma susceptibility genes and pancreatic cancer, neural system tumors, and uveal melanoma across GenoMEL. Goldstein, A.M., Chan, M., Harland, M., Gillanders, E.M., Hayward, N.K., Avril, M.F., Azizi, E., Bianchi-Scarra, G., Bishop, D.T., Bressac-de Paillerets, B., Bruno, W., Calista, D., Cannon Albright, L.A., Demenais, F., Elder, D.E., Ghiorzo, P., Gruis, N.A., Hansson, J., Hogg, D., Holland, E.A., Kanetsky, P.A., Kefford, R.F., Landi, M.T., Lang, J., Leachman, S.A., Mackie, R.M., Magnusson, V., Mann, G.J., Niendorf, K., Newton Bishop, J., Palmer, J.M., Puig, S., Puig-Butille, J.A., de Snoo, F.A., Stark, M., Tsao, H., Tucker, M.A., Whitaker, L., Yakobson, E. Cancer Res. (2006)
- Association of MC1R variants and risk of melanoma in melanoma-prone families with CDKN2A mutations. Goldstein, A.M., Landi, M.T., Tsang, S., Fraser, M.C., Munroe, D.J., Tucker, M.A. Cancer Epidemiol. Biomarkers Prev. (2005)
- Prospective risk of cancer in CDKN2A germline mutation carriers. Goldstein, A.M., Struewing, J.P., Fraser, M.C., Smith, M.W., Tucker, M.A. J. Med. Genet. (2004)
- Rarity of CDK4 germline mutations in familial melanoma. Goldstein, A.M., Chidambaram, A., Halpern, A., Holly, E.A., Guerry IV, D., Sagebiel, R., Elder, D.E., Tucker, M.A. Melanoma Res. (2002)
- Genetic epidemiology of cutaneous melanoma: a global perspective. Goldstein, A.M., Tucker, M.A. Arch. Dermatol (2001)
- Genotype-phenotype relationships in U.S. melanoma-prone families with CDKN2A and CDK4 mutations. Goldstein, A.M., Struewing, J.P., Chidambaram, A., Fraser, M.C., Tucker, M.A. J. Natl. Cancer Inst. (2000)
- Gene-covariate interaction between dysplastic nevi and the CDKN2A gene in American melanoma-prone families. Goldstein, A.M., Martinez, M., Tucker, M.A., Demenais, F. Cancer Epidemiol. Biomarkers Prev. (2000)
